Companies: 10,795·Total market cap: $144.5T
VivoSim Labs, Inc.

VivoSim Labs, Inc.

VIVSNASDAQHealthcare● Active
$1.19
$-0.01(-0.83%)
Market Cap$3103472
P/E Ratio
52W High$5.3
52W Low$1.16

VivoSim Labs, Inc.(VIVS)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · VIVS · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-032024-032023-032022-032021-03
Revenue
Revenue$0.14M$0.11M$0.37M$1.50M$0.00M
Cost of Revenue$0.01M$0.00M$0.00M$0.00M$0.00M
Gross Profit$0.14M$0.11M$0.37M$1.50M$0.00M
Gross Margin %(computed)96.53%100.00%100.00%100.00%
Operating Expenses
R&D Expenses$5.03M$5.50M$8.88M$3.32M$1.10M
G&A Expenses$7.69M$9.64M$9.09M$9.63M$15.71M
Total Operating Expenses$12.76M$15.20M$18.10M$12.98M$16.83M
Operating Income($12.62M)($15.09M)($17.73M)($11.48M)($16.83M)
Operating Margin %(computed)-765.27%
Interest Income$0.14M$0.41M$0.45M$0.01M$0.01M
Interest Expense$0.01M$0.00M$0.00M$0.00M$0.00M
Income Before Tax($2.49M)($14.67M)($17.26M)($11.45M)($16.82M)
Income Tax Expense$0.00M$0.00M$0.00M$0.00M$0.00M
Net Income($2.49M)($14.67M)($17.26M)($11.45M)($16.83M)
Net Margin %(computed)-763.20%
Per Share & EBITDA
EPS (Basic)$-1.70$-19.25$-23.77$-15.78$-29.25
Wtd Avg Shares1.46M0.76M0.73M0.73M0.58M
EBITDA($2.21M)($14.81M)($17.44M)($11.34M)($16.79M)
EBITDA Margin %(computed)-755.80%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · M

深入了解VivoSim Labs, Inc.

关于VivoSim Labs, Inc.(VIVS)损益表

VivoSim Labs, Inc.(VIVS)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,VIVS实现营收$0.00B,毛利润$0.00B(毛利率96.53%),净利润($0.00B)(净利率-1727.78%)。

常见问题

VIVS · 4 问

VivoSim Labs, Inc.(VIVS)2025财年营收为$0.00B,同比up32.1%。

VIVS revenueVIVS salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08